Clinical trial Recruiting at 1 site Interventional Ages 40 to 80

Frequency-specific stimulation of subthalamic nucleus subregions to improve inhibitory control in Parkinson's disease

Official title: Frequency-dependent Modulation of Inhibitory Control Via Subthalamic Nucleus Subregional Stimulation in Parkinson's Disease

Run by Beijing Tiantan Hospital · NCT07022522 · Data updated 2026-11-12

This tests whether stimulating different parts of the subthalamic nucleus at low (5 Hz) or high (130 Hz) frequencies can improve inhibitory control in people with Parkinson's disease who have deep brain stimulation.

Quick facts

Study typeInterventional
Ages40 Years to 80 Years
SexAll
Enrollment20 (estimated)
SponsorBeijing Tiantan Hospital
Academic / other
Locations1 site (Beijing, Beijing Municipality)
StatusRecruiting
StartedOctober 1, 2024
Main results expectedFebruary 1, 2026
Study endsDecember 31, 2026
Registry record updatedJune 15, 2025
Trial IDNCT07022522 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are people aged 40–80 with idiopathic Parkinson's disease who meet DBS indications and do not have dementia or sensory impairments that would interfere with cognitive testing.

Probably not a fit

Patients with significant psychiatric disorders, dementia, major post-DBS complications (e.g., hemorrhage, electrode misplacement), sensory impairments, or other conditions that impair cognition are unlikely to benefit from the tested interventions.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Participants with idiopathic Parkinson's disease who meet indications for DBS will receive sequential stimulation conditions targeting either the motor or associative subregions of the subthalamic nucleus at 5 Hz or 130 Hz, plus a no-stimulation control. During each condition they will perform cognitive tasks that measure inhibitory control to compare performance across frequencies and contact locations. The design compares within-subject effects of frequency and subregion to identify patterns that improve or worsen inhibitory control. Results will inform whether specific frequency–subregion combinations produce reliably better cognitive outcomes in the acute setting.

Why it matters

Potential benefit: If successful, this could allow clinicians to tailor DBS frequency and contact location to reduce impulsivity and improve attention and daily functioning for patients with Parkinson's disease.

How similar studies have gone: Prior work shows STN stimulation frequency and contact location can influence motor and cognitive outcomes, but applying frequency-specific stimulation across defined STN subregions specifically to improve inhibitory control is a relatively novel approach with mixed prior results.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Age 40-80 years old;
2. Diagnosed with idiopathic Parkinson's disease;
3. Meeting the indications for DBS surgery.

Exclusion Criteria:

1. Patient declined to participate in the study;
2. Presence of significant post-DBS complications (e.g., intracranial hemorrhage, cerebral edema, electrode misplacement);
3. Significant psychiatric disorders or dementia (MMSE score \<20 for uneducated; \<23 for 1-6 years education; \<27 for ≥7 years education);
4. Visual or auditory impairment affecting cognitive task performance
5. History of conditions potentially impairing cognitive function.

Where it's running

  • Beijing Tiantan Hospital, Capital Medical University
    Beijing, Beijing Municipality, China
    Recruiting

Study contacts

  • Principal investigator: Jianguo Zhang, M.D., Ph.D. — Beijing Tiantan Hospital
  • Study coordinator: Hutao Xie
  • Email: xieht0123@163.com
  • Phone: +8618756921517

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.